Sogen Data · Datasets · 数据专题

黑色素瘤复发轴数据集锦

空转 · bulk 转录组

本专题承自 Sogen Data 数据整理体系,逐条人工复核,附研究设计、样本量、平台与 GEO/PubMed 直达链接。

人源空转

Human · Spatial

  1. 01 GSE282437 对 stage III 黑色素瘤患者肿瘤引流淋巴结(TDLNs)的副皮质区进行数字空间转录组分析,分别检测 CD8+、CD11c+ 和 CD68+ 细胞的转录组特征,比较长期 (>5 年) 疾病控制与早期 (<2 年) 疾病复发患者的免疫细胞组成及相互作用网络差异。 人源 · 69 例 · GPL11154 · 2026/06/23

    设计对 stage III 黑色素瘤患者肿瘤引流淋巴结(TDLNs)的副皮质区进行数字空间转录组分析,分别检测 CD8+、CD11c+ 和 CD68+ 细胞的转录组特征,比较长期 (>5 年) 疾病控制与早期 (<2 年) 疾病复发患者的免疫细胞组成及相互作用网络差异。

    摘要Current cancer immunotherapies can induce tumor regression, although responses are often not durable for reasons that are incompletely understood. Apart from activating pre-existing tumor-infiltrating T cells, recent studies have highlighted the importance of enforcing a systemic immune response from tumor-draining lymph nodes (TDLNs). However, mechanisms driving immune suppression in TDLNs remain poorly studied. We applied spatial proteogenomics on melanoma TDLNs and identified striking regional differences in immune cell composition in lymph nodes from patients with long-term (>5 years) disease control compared to those with early (<2 years) disease recurrence. TDLNs from patients with a poor prognosis were characterized by the expansion of a specific cellular interaction network in the lymph node paracortex, consisting of regulatory T cells (Tregs), dendritic cells (DCs) and macrophages interacting with cytotoxic CD8+ T cells. Targeted transcriptomics of cell types within this spatial neighbourhood revealed immunoregulatory myeloid cell phenotypes engaging with CD8+ T cells poised for exhaustion. Macrophages in patients with early disease recurrence resided in a dysfunctional state bearing hallmarks of chronic interferon-signalling – frequently residing near CD8+ T-cell–DC dyads. Besides known immune-suppressive molecules such as IDO and PD-L1, paracortex macrophages and DCs in patients with recurrence expressed high levels of the secreted phospholipase PLA2G2D across different cancer types. In addition, PLA2G2D was upregulated in non-small cell lung cancer patients upon acquired resistance to anti-PD-1 immunotherapy. Importantly, PLA2G2D loss-of-function or therapeutic inhibition markedly improved survival in tumor-bearing mice and increased the efficacy of anti-PD-1 immunotherapy. Collectively, we show that in-depth spatial profiling of cancer patient TDLNs offers novel insights into systemic anti-tumor immunity and identifies PLA2G2D as a target for cancer immunotherapy.

人源bulk 转录组

Human · Bulk RNA-seq

  1. 01 GSE46517 对人类黑色素瘤样本进行批量RNA测序,比较痣、原发性及转移性黑色素瘤样本的基因表达特征。 人源 · 121 例 · GPL96 · 2013/05/01

    设计对人类黑色素瘤样本进行批量RNA测序,比较痣、原发性及转移性黑色素瘤样本的基因表达特征。

    摘要We sought to identify genes and gene signatures which correlate with progression by sampling human melanomas from nevi, primary, and metastatic tumors. The large number of samples also permits analysis within groups.

  2. 02 GSE43081 从97名前哨淋巴结阳性黑色素瘤患者中提取前哨淋巴结总RNA,按肿瘤复发状态分为复发组(39例)与非复发组(58例),通过微阵列分析检测基因表达差异,比较两组间SLN基因表达特征。 人源 · 97 例 · GPL570 · 2016/09/29

    设计从97名前哨淋巴结阳性黑色素瘤患者中提取前哨淋巴结总RNA,按肿瘤复发状态分为复发组(39例)与非复发组(58例),通过微阵列分析检测基因表达差异,比较两组间SLN基因表达特征。

    摘要To identify a panel of Seninel Lymph Node (SLN) genes to aid in risk stratification of patients with tumor-positive SLN, total SLN RNA from 97 SLN-positive melanoma patients were chosen from the Sunbelt Melanoma Trial. Microarray experiments were performed to screen SLN genes in recurrence (=39) versus non-recurrence (=58) group. We identified 20 differentially expressed SLN genes in the recurrence vs. the non-recurrence group.

  3. 03 GSE123728 对可切除黑色素瘤患者的临床和免疫学特征样本进行基因表达谱分析,采用定制 Nanostring 基因面板检测总 RNA 表达,比较复发与非复发患者的基因表达差异。 人源 · 24 例 · GPL25929 · 2019/02/11

    设计对可切除黑色素瘤患者的临床和免疫学特征样本进行基因表达谱分析,采用定制 Nanostring 基因面板检测总 RNA 表达,比较复发与非复发患者的基因表达差异。

    摘要To understand some of the potential determinants of anti-PD-1 response and resistance in this cohort we used Nanostring analysis to study/compare the expression of custom set of genes

  4. 04 GSE79662 将福尔马林固定石蜡包埋的薄型黑色素瘤组织样本按预后结果分为不良组(9例)与良好组(10例),采集总RNA进行基因表达分析,比较两组间基因表达差异。 人源 · 19 例 · GPL17586 · 2017/01/15

    设计将福尔马林固定石蜡包埋的薄型黑色素瘤组织样本按预后结果分为不良组(9例)与良好组(10例),采集总RNA进行基因表达分析,比较两组间基因表达差异。

    摘要Melanoma is the fifth-most common cancer diagnosed in the United States with a dramatic increase in incidence among both men and women. Most melanomas present as thin lesions (≤1.0mm) and have a good prognosis. However a small percentage of patients (5-10%) with thin lesions recur or metastasize. The aim of our study was to elucidate which thin melanomas (< 1.0 mm thickness) have the propensity to metastasize to regional lymph nodes or distant sites. Our focus was analyzing gene expression as a whole. We sought to identify a distinct pattern of gene expression within thin melanomas that were known to have eventually metastasized to regional lymph nodes or distant sites, from those that followed the typical course with good response to wide local excision alone. While gene expression differences were observed between nine thin melanoma patients with poor clinical outcome compared to ten patients with a good clinical outcome, neither the number of genes nor the magnitude of the fold difference was very substantial or significant. Although cluster analysis was able to use this subset of genes to definitively separate a subset of the poor responders from the good responders, there remained a mixed group of tumors which could not be predicted from gene expression alone. Pathway analysis did identify cellular processes that were regulated based upon response, including categories commonly associated with melanoma progression The goal of this pilot study was to identify gene expression changes within the tumor cells of thin melanomas that have a poor outcome that would discriminate them from thin melanomas that do not recur or metastasize . Our results conclude that there were very few differences between these groups. Future research will be required and investigation of the mutational landscape of these different tumor sub-types may be another strategy to uncover genomic changes that drive recurrence and metastasis.

  5. 05 GSE77940 对黑色素瘤患者的治疗前和复发后肿瘤样本进行RNA测序,比较不同时间点的基因表达差异。样本量为12,分为治疗前和复发后两组,每组6个样本,来自接受RAF或RAF+MEK抑制剂治疗的患者。 人源 · 12 例 · GPL16791 · 2016/02/25

    设计对黑色素瘤患者的治疗前和复发后肿瘤样本进行RNA测序,比较不同时间点的基因表达差异。样本量为12,分为治疗前和复发后两组,每组6个样本,来自接受RAF或RAF+MEK抑制剂治疗的患者。

    摘要RNA-seq of pre-treatment and post-relapse matched samples from melanoma patients

微信二维码

课题合作 · 扫码加微信

bioinformaticsboy